3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Ventricular Dysfunction
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hypertension
1
Essential Hypertension
1
Cardiotoxicity
1
Breast Neoplasms
1
Interventions
Methotrexate
48
Cyclophosphamide
47
Vincristine
39
Cytarabine
36
Dexamethasone
33
Mercaptopurine
32
pegaspargase
30
Doxorubicin
29
Daunorubicin
26
Etoposide
24
Asparaginase
23
Prednisone
22
Radiotherapy
18
Thioguanine
15
Leucovorin
14
Calcium Dobesilate
14
merphos
12
Prednisolone
12
blinatumomab
11
Hydrocortisone
10
Whole-Body Irradiation
9
dexamethasone acetate
8
azathiopurine
8
Methylprednisolone
8
Ifosfamide
8
Filgrastim
8
Cyclosporine
8
fludarabine
7
dexamethasone 21-phosphate
7
auricularum
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Enalapril
×
Clear all
NCT01110824
2013-11-15
OVERCOME
Hospital Clinic of Barcelona
Phase 3
Completed
90 enrolled